OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business developments for 5 p.m. ET on May 6, ...

Enters into Cooperation Agreement with Altai CapitalBoard to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, ...

OraSure Technologies (OTI) has reached a truce with an activist investor who has been extremely critical of the medtech ...

OraSure ticked higher by 0.3% after entering a cooperation pact with activist Altai Capital and naming John D. Bertrand to ...

BETHLEHEM, Pa. - OraSure Technologies Inc., a maker of diagnostic tests, reported second-quarter revenue of $85.4 million, exceeding the company's own forecast and the consensus estimate of Wall ...

On April 12, 2024, OraSure Technologies, Inc. (“OraSure”) filed a notice with the Securities and Exchange Commission after discovering that an unauthorized party was able to gain access to its ...

OraSure Technologies, Inc. has announced that it will hold anearnings conference callon May 7, 2025, at 5 p.m. ET to discuss its first quarter financial results and business developments. The call ...

After increasing its stake in the infectious disease testmaker last year, Altai Capital Management is now pushing OraSure Technologies to consider the sale of its entire business, along with a shift ...

After a steep drop in COVID-19 cases in the U.S. earlier this year sent test makers scaling back production of their rapid antigen and PCR offerings, they’re now scrambling to catch up with the sudden ...

Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to Force an Ill-Timed Sale Process BETHLEHEM, Pa., March 17, 2026 (GLOBE NEWSWIRE ...

OraSure Technologies Inc. is a health and wellness company specializing in "easy to use" diagnostic and specimen collection products. OraSure has a strong balance sheet and is trading below its net ...

Those are the three steps involved in the InteliSwab, the name of the long-awaited COVID-19 rapid test developed by Bethlehem’s OraSure Technologies Inc. that has now received emergency use ...